Improving the Safety of High-Flow Therapies in the Management of Patients With COVID-19
Chest
.
2020 Oct;158(4):1788-1789.
doi: 10.1016/j.chest.2020.06.040.
Authors
Yasmin M Madney
1
,
Antonio M Esquinas
2
,
Haitham Saeed
1
,
Hadeer S Harb
1
,
Mohamed E A Abdelrahim
3
Affiliations
1
Clinical Pharmacy Department, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt.
2
Intensive Care Unit, Hospital M. Meseguer, Murcia, Spain.
3
Clinical Pharmacy Department, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt. Electronic address: mohamedemam9@yahoo.com.
PMID:
33036099
PMCID:
PMC7533713
DOI:
10.1016/j.chest.2020.06.040
No abstract available
Publication types
Letter
Comment
MeSH terms
Aerosols
Betacoronavirus
COVID-19
Cannula*
Coronavirus Infections*
Humans
Insufflation*
Pandemics*
Pneumonia, Viral*
SARS-CoV-2
Substances
Aerosols